Abstract
Cancer chemotherapy is defined as the application of drugs that cause a lethal cytotoxic effect on malignant (cancerous) cells so as to arrest tumour cell progression. The cancer therapeutic agents can be Cell Cycle Specific (CCS) or Cell Cycle Non-Specific (CCNS) agents. Apart from complete cancer eradication (curative therapy), there are other modalities of cancer chemotherapy that are used for different purposes, such as salvage (rescue) therapy, adjuvant chemotherapy (post-operative), primary or neoadjuvant chemotherapy (pre-operative), palliative chemotherapy, direct instillation chemotherapy, and chemoradiotherapy. The two major determinants of anticancer chemotherapeutics usage are the occurrence of toxicities and resistance. Various local toxicities and systemic toxicities, including haematopoietic, gastrointestinal, nervous, metabolic, hepatic, cardiac, renal, urinary, pulmonary, reproductive, dermatological, and ocular toxicities are elaborated. Further, the several mechanisms behind anticancer drug resistance are also discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Bibliography
Beijers AJ, Jongen JL, Vreugdenhil G (2012) Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies. Neth J Med 70:18–25
Chu E (2018) Cancer chemotherapy. In: Katzung BG (ed) Basic & clinical pharmacology, 14th edn. McGraw-Hill Education, New York, pp 948–976
Chu E, DeVita VT Jr (2019) Principals of cancer chemotherapy. In: Physicians’ cancer chemotherapy drug manual 2020, 20th edn. Burlington, Jones & Bartlett Learning
Dong J, Chen H (2018) Cardiotoxicity of anticancer therapeutics. Front Cardiovasc Med 5:9. https://doi.org/10.3389/fcvm.2018.00009
Feeney K, Cain M, Nowak AK (2007) Chemotherapy induced nausea and vomiting--prevention and treatment. Aust Fam Physician 36:702–706
Florescu M, Cinteza M, Vinereanu D (2013) Chemotherapy-induced cardiotoxicity. Maedica (Buchar) 8:59–67
Hesketh PJ, Kris MG, Basch E, Bohlke K, Barbour SY, Clark-Snow RA et al (2017) Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 35:3240–3261. https://doi.org/10.1200/JCO.2017.74.4789
Housman G, Byler S, Heerboth S, Lapinska K, Longacre M, Snyder N, Sarkar S (2014) Drug resistance in cancer: an overview. Cancers (Basel) 6:1769–1792. https://doi.org/10.3390/cancers6031769
Izar B, Rotow J, Gainor J, Clark J, Chabner B (2013) Pharmacokinetics, clinical indications, and resistance mechanisms in molecular targeted therapies in cancer. Pharmacol Rev 65:1351–1395. https://doi.org/10.1124/pr.113.007807
Leger P, Limper AH, Maldonado F (2017) Pulmonary toxicities from conventional chemotherapy. Clin Chest Med 38:209–222. https://doi.org/10.1016/j.ccm.2017.01.002
Limper AH (2004) Chemotherapy-induced lung disease. Clin Chest Med 25:53–64. https://doi.org/10.1016/S0272-5231(03)00123-0
Livshits Z, Rao RB, Smith SW (2014) An approach to chemotherapy-associated toxicity. Emerg Med Clin North Am 32:167–203. https://doi.org/10.1016/j.emc.2013.09.002
Lundqvist EÅ, Fujiwara K, Seoud M (2015) Principles of chemotherapy. Int J Gynaecol Obstet 131:S146–S149. https://doi.org/10.1016/j.ijgo.2015.06.011
Mansoori B, Mohammadi A, Davudian S, Shirjang S, Baradaran B (2017) The different mechanisms of cancer drug resistance: a brief review. Adv Pharm Bull 7:339–348. https://doi.org/10.15171/apb.2017.041
NHS (2018 Jun 20) Northern Cancer Alliance, guidelines for community management of chemotherapy and systemic anticancer therapy induced toxicities within primary care [Internet]. http://www.northerncanceralliance.nhs.uk/wp-content/uploads/2018/11/NCA-Guidelines-for-Community-Management-of-Chemotherapy-Toxicity-v1.52.pdf. Accessed 15 Jun 2020
Quintanilha JCF, Berlofa M (2017) New promising approaches to treatment of chemotherapy-induced toxicities. In: Chemotherapy. AvidScience, Hyderabad, pp 2–52
Rao KV, Faso A (2012) Chemotherapy-induced nausea and vomiting: optimizing prevention and management. Am Health Drug Benefits 5:232–240
Schimmel KJ, Richel DJ, van den Brink RB, Guchelaar HJ (2004) Cardiotoxicity of cytotoxic drugs. Cancer Treat Rev 30:181–191. https://doi.org/10.1016/j.ctrv.2003.07.003
Singaraju M, Palaian S, Shankar PR, Shrestha S (2020) Safety profile and toxicity amelioration strategies of common adverse effects associated with anticancer medications. JPRI 32:18–30
Taillibert S, Le Rhun E, Chamberlain MC (2016) Chemotherapy-related neurotoxicity. Curr Neurol Neurosci Rep 16:81. https://doi.org/10.1007/s11910-016-0686-x
Tomida A, Tsuruo T (2001) Drug resistance pathways as targets. In: Baguley B, Kerr D (eds) Anticancer drug development, 1st edn. Academic Press, Cambridge, pp 77–90
Tripathi KD (2019) Anticancer drugs. In: Essentials of medical pharmacology, 8th edn. Jaypee Brothers Medical Publishers, New Delhi, pp 915–936
Verstappen CC, Heimans JJ, Hoekman K, Postma TJ (2003) Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs 63:1549–1563. https://doi.org/10.2165/00003495-200363150-00003
Wellstein A (2018) General principles in the pharmacotherapy of cancer. In: Brunton LL, Hilal-Dandan R, Knollmann BC (eds) Goodman & Gilman’s the pharmacological basis of therapeutics, 13th edn. McGraw-Hill Education, New York, pp 1161–1166
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Priyadarshini, R. (2021). General Principles of Cancer Chemotherapy. In: Paul, A., Anandabaskar, N., Mathaiyan, J., Raj, G.M. (eds) Introduction to Basics of Pharmacology and Toxicology. Springer, Singapore. https://doi.org/10.1007/978-981-33-6009-9_62
Download citation
DOI: https://doi.org/10.1007/978-981-33-6009-9_62
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-33-6008-2
Online ISBN: 978-981-33-6009-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)